ABL103

· ABL Bio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABL103, covering 2025-09-08 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]